BioMarin Pharma gets DOJ subpoena on certain drug testing programs

 BioMarin Pharmaceutical has received a subpoena from the U.S. Department of Justice seeking information about the company's sponsored testing programs related to two treatments, it said in a filing on Monday.

BioMarin did not immediately respond to a Reuters request seeking additional information. 

https://www.marketscreener.com/quote/stock/BIOMARIN-PHARMACEUTICAL-I-8587/news/BioMarin-Pharma-gets-DOJ-subpoena-on-certain-drug-testing-programs-46031651/